Skip to content

Neuronal osciallations in basal-ganglia-loops and their therapeutic modulation in patients with idiopathic Parkinson syndrome.

Neuronal osciallations in basal-ganglia-loops and their therapeutic modulation in patients with idiopathic Parkinson syndrome.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006257
Enrollment
48
Registered
2014-07-08
Start date
2014-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: healthy volunteers, age-matched (EEG recording with a 128-channel-system from the head surface and synchronous measurment of the EMG from the right forearm during the conduction of simple mov
intraoperatively: the above mentioned electrophysiological measurements will be accompanied by the recording of local field potentials as well as single cell activity from the target structures of dee
perioperatively, in addition to EEG and EMG, local field potentials will be recorded by the use of externalized electrodes)

Sponsors

Uniklinik Köln, NeurologieArbeitsgruppe für Bewegungsstörungen und Tiefe Hirnstimulation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: • Male and female participants between 30 and 80 years of age • Right handed persons • Capability of signing an informed consent Parkinson’s patients: • Male and female patients with the diagnosis of an IPS according to the guidelines of the DGN • Right handed patients • Patients with the indication for receiving deep brain stimulation (target areas: STN, GPi, Vim) with uncontrollable motor symptomes due to strong dyskinesia and/ or ON/OFF fluctuations • positive motor response to L-Dopa or Apomorphine; • Patients between 30 and 80 (in order to exclude genetic variants of the disease); • time period of the symptomes longer than 4 years (differential diagnosis); • patients have to be able to sign an informed consent; • Ability to cooperate during the measurements

Exclusion criteria

Exclusion criteria: Healthy subjects: • non- "sui juris" patients, underaged persons as well as subjects which are judically sent to an institution • diagnosis of an idiopathic parkinson syndrom or any other neurological disease • participants that take drugs regularly which influence the nervous system and which can not be stopped the evening before the experiment • severe internal comorbidities • presence of psychiatric diseases •impaired vision or hearing defect that may hinder the testing • pregnant or breast feeding mothers Parkinson’s patients: • non- "sui juris" patients, underaged persons as well as subjects which are judically sent to an institution • patients that suffer from another neurological disease apart from Parkinsons like Epilepsy, Alzheimers or Dystonia • patients with severe frontal executive disturbances • presence of a Parkinson-Plus-Syndrom like corticobasal degeneration, progressive supranuclear palsy or multisystem atrophy • other hypokinetic movement disorders like MPTP- or manganese intoxication, chorea Huntington, subcortical arteriosclerotic encephalopathy or psychogenic movement disorder • clinically relevant abnormalities in preoperative MR-Images like ischemia, or cerebral athropy • previous surgeries in the ZNS due to, for example, brain tumors, epilepsy or vascular reasons • severe internal comorbidities • presence of psychiatric diseases • impaired vision or hearing defect that may hinder the testing • pregnant or breast feeding mothers

Design outcomes

Primary

MeasureTime frame
Pathological, oscillatory coupling between EEG and EMG in the beta range (13-30 Hz) on different measurement days without treatment

Secondary

MeasureTime frame
Comparision of pathological, electrophysiological acitivity for two Parkinsons-Subtypes (tremor-dominant versus akinetic rigid)

Countries

Germany

Contacts

Public ContactElfriede Stubbs

Klinik und Poliklinik für NeurologieArbeitsgruppe Bewegungsstörungen und Tiefe HirnstimulationStudienbüro

elfriede.stubbs@uk-koeln.de0221-478-98842

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026